Cargando…
An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy
INTRODUCTION: Cannabidiol (CBD) has antiseizure properties but no psychoactive effects. Randomized controlled trials of an oral, pharmaceutical formulation of highly purified CBD are promising; however, data regarding other formulations are sparse and anecdotal. We evaluated the effectiveness of add...
Autores principales: | Marchese, Francesca, Vari, Maria Stella, Balagura, Ganna, Riva, Antonella, Salpietro, Vincenzo, Verrotti, Alberto, Citraro, Rita, Lattanzi, Simona, Minetti, Carlo, Russo, Emilio, Striano, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070734/ https://www.ncbi.nlm.nih.gov/pubmed/33998856 http://dx.doi.org/10.1089/can.2019.0082 |
Ejemplares similares
-
New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment
por: Riva, Antonella, et al.
Publicado: (2021) -
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
por: Balagura, Ganna, et al.
Publicado: (2020) -
A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients
por: Dubois, Sara, et al.
Publicado: (2020) -
Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut Syndrome
por: Lattanzi, Simona, et al.
Publicado: (2021) -
“Comorbidity” between epilepsy and headache/migraine: the other side of the same coin!
por: Striano, Pasquale, et al.
Publicado: (2011)